miR-18b增强乳腺癌MDA-MB-231细胞对顺铂化疗敏感性的作用及其机制

doi:10.13481/j.1671-587x.20150222

Abstract

Abstract:

Objective To investigate the effect of miR-18b on the chemosensitivity of human breast cancer MDA-MB-231 cells,and to elucidate its possible mechanism.Methods The breast cancer MDA-MB-231 cells were divided into MDA-MB-231 group,MDA-MB-231+DDP group,MDA-MB-231-NC group,MDA-MB-231-NC+DDP group,MDA-MB-231 mimic group,and MDA-MB-231 mimic+DDP group.The target gene of miR-18b was predicted by bioinformatics method;Dual-luciferase Reporter Assay was used to demonstrate the binding of miR-18b 3' UTR of targets;Western blotting method was used to analyze the expression levels of ATM protein;qRT-PCR method was used to detect the expression levels of miR-18b in MDA-MB-231 cells;CCK-8 method was used to detect the inhibitory rate of growth of MDA-MB-231 cells.Results The Luciferase results showed that the ATM was the target gene of miR-18b-MB-231,which combined with the ATM 3'UTR sequence part;compared with MDA-MB-231 group, the expression levels of miR-18b in the MDA-MB-231 cells in MDA-MB-231 mimic group and MDA-MB-231 mimic+DDP group were increased(P<0.05).The Western blotting results showed that comared with MDA-MB-231 group,the expression level of ATM protein in MDA-MB-231 group was increased(P<0.05).Compared with MDA-MB-231-NC group,the expression level of ATM protein of the cells in MDA-MB-231 mimic group was decreased(P<0.05);compared with MDA-MB-231-NC+DDP group,the expression level of ATM protein of the cells in MDA-MB-231 mimic+DDP group was decreased(P<0.05).The CCK-8 results showed that compared with MDA-MB-231-NC group,after treated with different concentrations of DDP,the inhibitory rates of the proliferation of the cells in MDA-MB-231 mimic group were increased.Conclusion miR-18b can enhance the chemosensitivity of human breast cancer MDA-MB-231 cells to DDP through target-regulating ATM protein.

Key words: breast neoplasms, ataxia-telangiectasia mutated gene, cisplatin, miR-18b

CLC Number:

R737.9

CHEN Jingnan, WANG Yang, JIN Donghui, LU Xiaomei. Enhancement effect of miR-18b on chemosensitivity of human breast cancer MDA-MB-231 cells to DDP and its mechanism[J].Journal of Jilin University Medicine Edition, 2015, 41(02): 316-320.

References

[1] Dar A,Ma S,Rittsteuer C,et al. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression[J]. Natl Cancer Inst,2013,105(6):433-442.

[2] Cookson VJ,Bentley MA,Hogan BV,et al. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours[J].Cell Oncol,2012,35(4):301-308.

[3] Fonseca-Sanchez MA,Perez-Plasencia C,Fernandez-Retana J,et al. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration[J]. Oncol Rep,2013,30(5):2399-2410.

[4] Siegel R,Naishadham D,Jemal A,et al. Cancer statistics[J].CA Cancer Clin,2013,63(1):11-30.

[5] Yadav BS,Sharma SC,Chanana P,et al.Systemic treatment strategies for triple-negative breast cancer[J]. Clin Oncol,2014,5(2):125-133.

[6] Hoeferlin LA,E Chalfant C,Park MA. Challenges in the treatment of triple negative and HER2-overexpressing breast cancer[J]. Surg Sci,2013,1(1):3-7.

[7] Sirohi B. Amedos M,Popat S,et al. Platinum based chemotherapy in triple negative breast carcer[J].Ann Oncol,2008,19(11):1847-1852.

[8] Bouchalova K,Kharaishvili G,Bouchal J,et al. Triple negative breast cancer-BCL2 in prognosis and prediction[J]. Review,2014,15(12):1166-1175.

[9] 石永国,卞卫和,何烨,等. miR-206对三阴性乳腺癌细胞的增殖抑制作用及初步机制研究[J]. 临床肿瘤学杂志,2013,18(12):1062-1065.

[10] Zhao Z,Li R,Sha S,et al. Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation[J].Cancer Biol Ther,2014,15(10):1404-1412.

[11] Bischoff A,Huck B,Keller B,et al. miR-149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion[J]. Cancer Res,2014,74(18):5256-5265.

[12] 项丹,姜藻,顾晓怡. 西达本胺联合顺铂对三阴性乳腺癌细胞株MDA-MB-231的体外抗增殖作用及其机制的研究[J]. 东南大学学报:医学版,2013,32(3):283-288.

[13] 张梦怡,陈鹰,陈建华,等.多肽P161联合顺铂对乳腺癌 MA-782 细胞株增殖和凋亡的影响[J].中国药师,2013,16(12):1768-1771.

[14] Bennett PE,Bemis L,Norris DA,et al. miR in melanoma development:miRNAs and acquired hallmarks of cancer melanoma[J].Physiol Genomics,2013,45(22):1049-1059.

[15] Murakami Y,Tamori A,Itami S. The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis[J].BMC Cancer,2013,99(13):1471-1482.

[16] 章国晶,郭放,谢晓东.2012版美国国立综合癌症网络乳腺癌指南更新要点及研究进展荟萃[J].中国实用内科杂志,2013,33(2):127-130.

[17] 史中平,周建荣.乳腺化疗相关症状随疗程的变化趋势[J].中国老年学杂志,2013,33(10):2346-2348.

Enhancement effect of miR-18b on chemosensitivity of human breast cancer MDA-MB-231 cells to DDP and its mechanism

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	YU Xiuyan, ZHANG Xiaowei, CONG Zhanjie, LI Ting, WU Xuefeng. Detection of serum hMAM and CD147 levels of patients with breast cancer and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1269-1274.
[2]	ZHENG Fang, OUYANG Zhengren, OUYANG Jinglin, ZHOU Shili, LUO Wen. Analysis on correlations between ultrasound features and positive expressions of CerbB-2and Ki-67 in patients with breast cancer [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1073-1077.
[3]	LI Xiao, QIU Xiang, MA Zhenhui, TIAN Yaping. Skin metastatic carcinoma complicated with herpes zoster:A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 825-827.
[4]	YU Yunhe, DU Ye, HAN Bing, LI Sijie, SONG Lelian, FAN Zhimin. Observation on curative effects of neoadjuvant chemotherapy for different subtypes of Luminal B breast cancer and analysis on its prognosis [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 356-362.
[5]	MA Hongyun, ZHUANG Xinming, XU Weiguo, LIU Yi. Inhibitory effects of hyaluronic acid nanoparticles loading doxorubicin and cisplatin on allograft breast cancer in mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 243-248.
[6]	QI Yali, LIU Yang, LIANG Shuo, GONG Shouliang, WANG Zhicheng, LIU Weiwu. Effects of Smac overexpression mediated by triple-targeting on apoptosis and cell cycle progression of breast cancer MDA-MB-231 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 90-94.
[7]	MA Xiaotian, YUE Xiaoxin, RONG Shouhua, ZHANG Yuchao, TIAN Yuan, SHI Ying, LI Junfang, JIA Liting. Inhibitory effect of miR-200c on epithelial-mesenchymal transiton in triple negative breast cancer and its mechanism [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 106-110.
[8]	GAO Xinya, ZHANG Weijie, CUI Li, ZHOU Xueliang, MA Zhijun, LYU Zhuan, CHI Yanyan, WANG Liuxing. Expression of TM4SF1 in breast cancer tissue and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1186-1192.
[9]	NIU Huikun, QU Yangming, LI Meiqi, LI Lu, LYU Xin, SONG Yuanyuan, GAO Chunshi, LI Bo. Meta-analysis on efficacy and adverse effects of neoadjuvant chemotherapy combined with capecitabine in treatment of breast cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1171-1176.
[10]	DENG Ziliang, WANG Sen, LI Peng, XIE Kuilong, LI Shuxian, ZHOU Shixiong, HE Xiaozhou, CHEN Dong, GUO Hongsheng. Enhancement of IL-37 in chemosensitivity of cervical cancer HeLa cells to cisplatin [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 862-866.
[11]	YU Xiuyan, ZHANG Xiaowei, YE Lili, LI Ting, LIU Xiaofeng, WU Xuefeng. Application of detection of expressions of hMAM combined with MMP-9 and C-erbB2 mRNA in peripheral blood in diagnosis of micrometastases of breast cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1009-1014.
[12]	WEN Simin, YU Duo, LYU Xin, WANG Tiejun. Influence of docetaxel combined with cisplatinand single-agent cisplatin concurrent chemoradiotherapy in prognosis of patients with advanced cervical cancer and evaluation on security [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1002-1008.
[13]	ZHAO Peng, FU Tong, ZHANG Xiuxiang, ZHAN Yue, GUAN Xin, SHI Aiping. A case report of breast cancer complicated with thyroid cancer and dermatomyositis and literature review about relationships between three kinds of diseases [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1015-1018.
[14]	REN Aihua, WANG Dawei. Influence ofHiwigene targeting silencein chemotherapy sensitivity of breast cancerMCF-7/ADMcells [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 743-746.
[15]	WANG Jianan, FENG Hui, WANG Qian, HE Yueming, SONG Yanqiu, ZHU Jihong. Killer effect of natural killer cells combined with tamoxifen on breast cancer cells in vitro and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 281-287.